Synflorix vaccine
Use of Synflorix vaccine
A single dose of the vaccine is 0.5 ml. The vaccine is indicated for immunization of newborns and children from 6 weeks to 5 years. The vaccine should be administered intramuscularly, in the thigh or deltoid muscle. Intravenous and subcutaneous administration of the vaccine is strictly prohibited.
Before vaccination, it is recommended to examine the child and exclude contact with SARS patients.
Patients should be under medical supervision for 30 minutes after administration of the vaccine.
-
What are the indications for Synflorix vaccine?
Conjugate vaccine for the prevention of pneumococcal infection caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive serotype 19A (including sepsis, meningitis, pneumonia, bacteremia and acute medium otitis), as well as acute otitis media caused by atypical Haemophilus influenzae .
-
What are the contraindications to the Synflorix vaccine?
Hypersensitivity to any component of the vaccine, if a neurological complication was detected after previous vaccination.
Vaccination is not given to children who have diseases accompanied by fever, who have a history of convulsions, as well as children who suffer from epilepsy and encephalopathy.
-
What are the side effects of Synflorix vaccine?
After vaccination can be observed:
- drowsiness,
- loss of appetite
- irritability,
- temperature rise,
- redness,
- sealing at the injection site,
- pain at the injection site.
In the presence of mechanical inclusions or a strange color of the suspension, the use of the vaccine is unacceptable.
recommend
Recommended by the Ministry of Health
Not available